medjournalМедицинский журналMedical Journal1818-426XБелорусский государственный медицинский университет10.51922/1818-426X.2024.2.14medjournal-113Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESN-ацетилцистеин: возможности и перспективы применения при инфекциях мочевыводящих путейN-acetyl cysteine: possibilities and prospects for use in urinary tract infectionsГаврусевА. А.GavrusevA. A.УО «Белорусский государственный медицинский университет»Belarus202418062025021418Copyright © Гаврусев А.А., 20252025Гаврусев А.А.Gavrusev A.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://medjournal.ejournal.by/jour/article/view/113

Представлен обзор литературных данных о перспективах применения ацетилцистеина в терапии инфекций мочевыводящих путей. Кроме известного муколитического эффекта АЦЦ обладает антибактериальными, противовоспалительными и антиоксидантными свойствами. Ряд исследований выявили у АЦЦ способность подавлять развитие бактериальных биопленок, что имеет значение в лечении хронических инфекций, в том числе мочевыводящих путей. Также в исследованиях продемонстрирована противовоспалительная активность АЦЦ, выраженная в снижении выработки интерлейкинов. Представляет интерес свойство АЦЦ подавлять уреазу Proteus mirabilis, одного из основных возбудителей назокомиальной инфекции в урологии. Данное свойство АЦЦ может быть использовано в профилактике инфекции, ассоциированной с мочевыми катетерами и инкрустациями мочеточниковых стентов.

A review of literature data on the prospects for the use of acetylcysteine in the treatment of urinary tract infections is presented. In addition to the well-known mucolytic effect, ACC has antibacterial, anti-inflammatory and antioxidant properties. A number of studies have revealed the ability of ACC to suppress the development of bacterial biofilms, which is important in the treatment of chronic infections, including urinary tract infections. Studies have also demonstrated the anti-inflammatory activity of ACC, expressed in a decrease in the production of interleukins. Of interest is the property of ACC to suppress urease Proteus mirabilis, one of the main causative agents of nasocomial infection in urology. This property of ACC can be used in the prevention of infections associated with urinary catheters and ureteral stents incrustations.

ацетилцистеин (АЦЦ)инфекция мочевыводящих путей (ИМП)бактериальные биопленкиинфекцияассоциированная с мочевыми катетерами и стентамиN-acetylcysteine (NAC)urinary tract infection (UTI)bacterial biofilmscatheter-associated infectionsureteral stent-associated infectionsReferencesHulscher, M. E. J. L., Grol R. P. T. M., Van Der Meer J. W. M. Antibiotic prescribing in hospitals: a social and behavioural scientific approach // Lancet Infect. Dis. – 2010. – Vol. 10, № 3. – P. 167–175.Hulscher, M. E. J. L., Grol R. P. T. M., Van Der Meer J. W. M. Antibiotic prescribing in hospitals: a social and behavioural scientific approach / M. E. J. L. Hulscher, R. P. T. M. Grol, J. W. M. Van Der Meer / Lancet Infect. Dis. – 2010. – Vol. 10, № 3. – P. 167–175.The multifaceted therapeutic role of N-acetylcysteine (NAC) in disorders characterized by oxidative stress / G. Raghu, M. Berk, P. Campochiaro / Curr Neuropharmacol. – 2021. – Vol. 19, № 8. – P. 1202–1224.The multifaceted therapeutic role of N-acetylcysteine (NAC) in disorders characterized by oxidative stress / G. Raghu, M. Berk, P. Campochiaro / Curr Neuropharmacol. – 2021. – Vol. 19, № 8. – P. 1202–1224.Saddadi, F., Alatab S., Pasha F. The effect of treatment with N-acetylcysteine on the serum levels of C-reactive protein and interleukin-6 in patients on hemodialysis / F. Saddadi, S. Alatab, F. Pasha [et al.] // Saudi J Kidney Dis Transpl. – 2014. – Vol. 25, № 1. – P. 66.Saddadi, F., Alatab S., Pasha F. The effect of treatment with N-acetylcysteine on the serum levels of C-reactive protein and interleukin-6 in patients on hemodialysis / F. Saddadi, S. Alatab, F. Pasha [et al.] // Saudi J Kidney Dis Transpl. – 2014. – Vol. 25, № 1. – P. 66.Domenech, M., García E. N-Acetyl-l-Cysteine and Cysteamine as New Strategies against Mixed Biofilms of Nonencapsulated Streptococcus pneumoniae and Non-typeable Haemophilus influenza / M. Domenech, E. García / Antimicrob. Agents Chemother. – 2017. – Vol. 61, № 2. – P. e01992–16.Domenech, M., García E. N-Acetyl-l-Cysteine and Cysteamine as New Strategies against Mixed Biofilms of Nonencapsulated Streptococcus pneumoniae and Non-typeable Haemophilus influenza / M. Domenech, E. García / Antimicrob. Agents Chemother. – 2017. – Vol. 61, № 2. – P. e 01992–16.Zhao, T., Liu Y. N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa / T. Zhao, Y. Liu // BMC Microbiol. – 2010. – Vol. 10. – P. 140.Zhao, T., Liu Y. N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa / T. Zhao, Y. Liu // BMC Microbiol. – 2010. – Vol. 10. – P. 140.Cammarota, G., Branca G., Ardito F. Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial / G. Cammarota, G. Branca, F. Ardito [et al.] // Clin. Gastroenterol. Hepatol. – 2010. – Vol. 8, № 9. – P. 817–820.Cammarota, G., Branca G., Ardito F. Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial / G. Cammarota, G. Branca, F. Ardito [et al.] // Clin. Gastroenterol. Hepatol. – 2010. – Vol. 8, № 9. – P. 817–820.Olsson, B., Johansson M., Gabrielsson J. Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine / B. Olsson, M. Johansson, J. Gabrielsson [et al.] // Eur. J. Clin. Pharmacol. – 1988. – Vol. 34. – P. 77–82.Olsson, B., Johansson M., Gabrielsson J. Pharmaco-kinetics and bioavailability of reduced and oxidized N-acetylcysteine / B. Olsson, M. Johansson, J. Gabrielsson [et al.] // Eur. J. Clin. Pharmacol. – 1988. – Vol. 34. – P. 77–82.Szkudlarek, U., Zdziechowski A., Witkowski K. Effect of inhaled N-acetylcysteine on hydrogen peroxide exhalation in healthy subjects / U. Szkudlarek, A. Zdziechowski, K. Witkowski / Pulmonary pharmacology & therapeutics. – 2004. – Vol. 17. – P. 155–162.Szkudlarek, U., Zdziechowski A., Witkowski K. Effect of inhaled N-acetylcysteine on hydrogen peroxide exhalation in healthy subjects / U. Szkudlarek, A. Zdziechowski, K. Witkowski [et al.] / Pulmonary pharmacology & therapeutics. – 2004. – Vol. 17. – P. 155–162.Сosterton, J. W. Cystic fibrosis pathogenesis and the role of biofilms in persistent infection // Trends Microbiol. – 2001. – Vol. 9, № 2. – P. 50–52.Сosterton, J. W. Cystic fibrosis pathogenesis and the role of biofilms in persistent infection / J. W. Сosterton // Trends Microbiol. – 2001. – Vol. 9, № 2. – P. 50–52.Перепанова, Т. С. Значение инфекций, обусловленных образованием биопленок, в урологической практике / Т. С. Перепанова // Эффективная фармакотерапия. – 2013. – № 4. – C. 18–27.Perepanova, T. S. Znachenie infekcij, obuslovlennyh obrazovaniem bioplenok, v urologicheskoj praktike / T. S. Perepanova / Effektivnaya farmakoterapiya. – 2013. – Vol. 4. – P. 18–27.Tenke, P., Köves B., Nagy K. Update on biofilm infections in the urinary tract / P. Tenke, B. Köves, K. Nagy [et al.] // World. J. Urol. – 2012. – Vol. 30, № 1. – P. 51–57.Tenke, P., Köves B., Nagy K. Update on biofilm infections in the urinary tract / P. Tenke, B. Köves, K. Nagy [et al.] // World. J. Urol. – 2012. – Vol. 30, № 1. – P. 51–57.Marchese, A., Bozzolasco M., Gualco L. Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms / A. Marchese, M. Bozzolasco, L. Gualco [et al.] // Int. J. Antimicrob. Agents. – 2003. – Vol. 22, suppl. 2. – P. S95–100.Marchese, A., Bozzolasco M., Gualco L. Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms / A. Marchese, M. Bozzolasco, L. Gualco [et al.] // Int. J. Antimicrob. Agents. – 2003. – Vol. 22, Suppl. 2. – P. S95–100.Naves, P., del Prado G., Huelves L., Rodríguez-Cerrato V., Ruiz V., Ponte M. C. Effects of human serum albumin, ibuprofen and N-acetyl-L-cysteine against biofilm formation by pathogenic Escherichia coli strains / P. Naves, G. del Prado, L. Huelves, V. Rodríguez-Cerrato, V. Ruiz, M. C. Ponte [et al.] // J. Hosp. Infect. – 2010. – Vol. 76, № 2. – P. 165–70.Naves, P., del Prado G., Huelves L., Rodríguez-Cerrato V., Ruiz V., Ponte M. C. Effects of human serum albumin, ibuprofen and N-acetyl-L-cysteine against biofilm formation by pathogenic Escherichia coli strains / P. Naves, G. del Prado, L. Huelves, V. Rodríguez-Cerrato, V. Ruiz, M. C. Ponte [et al.] // J. Hosp. Infect. – 2010. – Vol. 76, № 2. – P. 165–70.Manoharan, A., Ognenovska S., Paino D. N-аcetylcysteine protects bladder epithelial cells from bacterial invasion and displays antibiofilm activity against urinary tract bacterial pathogens / A. Manoharan, S. Ognenovska, D. Paino // Antibiotics. – 2021. – Vol. 10. – P. 900.Manoharan, A., Ognenovska S., Paino D. N-Acetylcysteine protects bladder epithelial cells from bacterial invasion and displays antibiofilm activity against urinary tract bacterial pathogens / A. Manoharan, S. Ognenovska, D. Paino // Antibiotics. – 2021. – Vol. 10. – P. 900.Palleschi, G., Carbone A., Zanello P. P. Prospective study to compare antibiosis versus the association of N-acetylcysteine, D-mannose and Morinda citrifolia fruit extract in preventing urinary tract infections in patients submitted to urodynamic investigation / G. Palleschi, A. Carbone, P. P. Zanello // Archivio Italiano di Urologia e Andrologia. – 2017. – Vol. 89. – P. 1.Palleschi, G., Carbone A., Zanello P. P. Prospective study to compare antibiosis versus the association of N-acetylcysteine, D-mannose and Morinda citrifolia fruit extract in preventing urinary tract infections in patients submitted to urodynamic investigation / G. Palleschi, A. Carbone, P. P. Zanello // Archivio Italiano di Urologia e Andrologia. – 2017. – Vol. 89. – P. 1.Allameh, Z., Karimi A., Tabatabaei, R. S. Effect of N-acetylcysteine on inflammation biomarkers in pediatric acute pyelonephritis: A randomized controlled trial / Z. Allameh, A. Karimi, R. S. Tabatabaei [et al.] / Iran. J. Kidney Dis. – 2015. – Vol. 9. – P. 454–462.Allameh, Z., Karimi A., Tabatabaei R. S. Effect of N-acetylcysteine on inflammation biomarkers in pediatric acute pyelonephritis: A randomized controlled trial / Z. Allameh, A. Karimi, R. S. Tabatabaei [et al.] // Iran. J. Kidney Dis. – 2015. – Vol. 9. – P. 454–462.Aslam, S., Darouiche R. O. Role of antibiofilm-antimicrobial agents in control of device-related infections / S. Aslam, R. O. Darouiche // Int J Artif Organs. – 2011. – Vol. 34, № 9. – P. 752–758.Aslam, S., Darouiche R. O. Role of antibiofilm-antimicrobial agents in control of device-related infections / S. Aslam, R. O. Darouiche // Int J Artif Organs. – 2011. – Vol. 34, № 9. – P. 752–758.El-Feky, M. A., El-Rehewy M. S., Hassan M. A. Effect of ciprofloxacin and N-acetylcysteine on bacterial adherence and biofilm formation on ureteral stent surfaces / M. A. El-Feky, M. S. El-Rehewy, M. A. Hassan [et al.] / Pol. J. Microbiol. – 2009. – Vol. 58, № 3. – P. 261–7.El-Feky, M. A., El-Rehewy M. S., Hassan M. A. et al. Effect of ciprofloxacin and N-acetylcysteine on bacterial adherence and biofilm formation on ureteral stent surfaces / M. A. El-Feky, M. S. El-Rehewy, M. A. Hassan [et al.] // Pol. J. Microbiol. – 2009. – Vol. 58, № 3. – P. 261–7.Manoharan, A., Farrell J., Aldilla V. R. N-acetylcysteine prevents catheter occlusion and inflammation in catheter associated-urinary tract infections by suppressing urease activity / A. Manoharan, J. Farrell, V. R. Aldilla [et al.] // Front. Cell. Infect. Microbiol. – 2023. – Vol. 13. – P. 1–19.Manoharan, A., Farrell J., Aldilla V. R. N-acetylcysteine prevents catheter occlusion and inflammation in catheter associated-urinary tract infections by suppressing urease activity / A. Manoharan, J. Farrell, V. R. Aldilla [et al.] / Front. Cell. Infect. Microbiol. – 2023. – Vol. 13. – P. 1–19.

The authors declare that there are no conflicts of interest present.